Industry2d ago
Isomorphic Labs Secures $2.1 Billion For Drug Discovery
A $2.1 billion funding round fuels Isomorphic Labs as it deploys its new Drug Design Engine. The Google DeepMind spin-off partnered with Novartis and Eli Lilly to identify hidden drug targets. This technical pivot leverages protein structure prediction to bypass traditional trial-and-error. Success here proves AI can move beyond hype into clinical pipelines.